Attempted oestrus induction in four bitches using pregnant mare serum gonadotrophin

Two juvenile (9 months) and two adult (3 years) beagle bitches were injected with five doses (250 i.u. per dose) of pregnant mare serum gonadotrophin (PMSG) on alternate days. Plasma oestrogen concentrations rose in all bitches. In one adult bitch plasma progesterone concentrations remained basal and no signs of oestrus were shown; in the other there was a slight elevation of circulating progesterone values and she showed oestrus but did not conceive. Both the young bitches came into heat and had multiple ovulations, producing very high plasma progesterone concentrations. One of them conceived, and at laparotomy on the thirty-sixth day after the first mating seventeen conceptuses were seen; 14 days later ovarohysterectomy was performed and only five foetuses remained in the uterus.     

Superovulation in the cow with pregnant mare serum gonadotrophin: effects of dose and antipregnant mare serum gonadotrophin serum.

The effects of pregnant mare serum gonadotrophin (PMSG) dose and PMSG antiserum on superovulation in crossbred beef cows were studied. In experiment I, three groups were treated with 1200, 2400 or 3600 IU of PMSG and 48 h later with prostaglandin (PGF). The mean numbers of corpora lutea (CL), unovulated follicles, and total ova/embryos collected increased as the PMSG dose increased. The percent of fertilized ova and transferable embryos was lowest in the highest dose group (p < 0.05). In experiment II, all cows received 2500 IU of PMSG; groups 1 and 2 were treated with sheep anti-PMSG serum at 48 h or 60 h after PGF; group 3 cows were PMSG-only controls. The number of CL was lowest and the number of unovulated follicles highest in the PMSG-only group (p < 0.05). The number of CL was higher in group 2 (anti-PMSG at 60 h) than in the control group, with the anti-PMSG at 48 h not different from the other groups. Numbers of total ova/embryos, fertilized ova, and transferable embryos were higher (p < 0.05) in both antiserum-treated groups relative to the PMSG-only group. We conclude that superovulation of beef cows with PMSG and treatment with PMSG antiserum will induce a higher superovulatory response and will result in higher CL numbers and fewer unovulated follicles. Further, the variability in the superovulatory response to PMSG treatment was still evident when PMSG antiserum was administered.     

孕马血清(PMSG)粗品的提取

孕马血清促性腺激素（PMSG）是由孕马子宫内膜杯状细胞分泌到血液中的糖蛋白激素,具有FSH和LH的双重作用,在畜牧生产中主要作用于同期发情、超数排卵、胚胎移植的基础性科学研究,同时对动物和人体机能障碍有显著疗效;PMSG当用于诱发动物发情时,可大大提高动物保胎率与受胎率,还可提高繁殖率。     

Ovulation rate and egg recovery in cattle treated repeatedly with pregnant mare serum gonadotrophin and prostaglandin.

Fourteen heifers were superovulated five to 10 times using pregnant mare serum gonadotrophin (PMSG) and prostaglandin in a standardised regime which resulted in a mean interval of 42.1 days (SEM +/- 0.97) between treatments. There was a significant (P less than 0.02) fall in the mean ovulation rate at the second treatment when compared with the first but no significant difference between mean ovulation rate at the second and subsequent treatments. No significant difference between treatments in mean egg recovery rate or in the percentage of normal eggs recovered was demonstrated. Four heifers treated 10 times continued to respond with multiple ovulations on most occasions. At the end of the experiment 13 of the 14 heifers were inseminated and 12 conceived, requiring a mean of 1.67 services per pregnancy.     

Urinary oestrogen excretion in the goat during the oestrous cycle and after administration of pregnant mare serum gonadotrophin (PMSG)

Two goats were placed in cages constructed for urine collection. Samples were taken daily and stored in the frozen state until analysis. The urine was processed according to a method designed for determination of oestrone and oestradiol-17 α in bovine urine (Lunaas unpublished).     

The use of progesterone administered intravaginally and pregnant mare serum gonadotrophin given by injection in controlled breeding programs in beef and dairy cattle

Five experiments involving 1,244 cows and heifers were carried out to investigate the factors which might influence the calving performance to fixed-time artificial insemination following intravaginal administration of progesterone (PRID) and intramuscular injection of pregnant mare serum gonadotrophin (PMSG). Factors examined were duration of PRID treatment, time of treatment after calving, time and dose PMSG and lactational status. Experiments 1, 2 and 3 were carried out on milked Friesian cows, experiment 4 on Friesian heifers and experiment 5 on suckled and dry Herefords. All cows were inseminated once with frozen/thawed semen 54 to 58 h or 46 to 50 h after completion of PRID treatment. Overall there was a progressive increase in calving rates with an increase in the duration of treatment from 12 to 14 to 16 days but there was little or no effect of time after calving (4 v 7 weeks) at which treatment was commenced. The poorer calving performance of cows treated for 12 to 14 days was associated with relatively high peripheral levels of plasma progesterone at the time of the PRID removal, suggesting the presence at the end of treatment of residual secretory luteal tissue. There was an effect on calving performance of PMSG given at the time of PRID removal but its effect varied according to the duration of PRID treatment. After 12 days treatments (experiments 1 and 5) PMSG had little effect, whereas after 14 days treatments, 0, 500 and 750 IU PMSG gave calving rates of 27%, 40% and 46% in experiment 2 and 5%, 24% and 38% in experiment 5.(ABSTRACT TRUNCATED AT 250 WORDS)     

The effects of duration and concentration of plasma progesterone on the fertility of post-partum cows treated with pregnant mare serum gonadotrophin and intravaginal progesterone

The effects of duration of insertion of progesterone releasing devices (PRIDs) on the concentrations of plasma progesterone (plasma P4) and the relationship of these with fertility were examined respectively in ovariectomised and intact Bos taurus cattle. In experiment 1, ovariectomised cows (n = 14) were treated with PRIDs to produce high and low plasma P4 for 7 or 14 days giving 4 treatment groups designated H7, H14, L7 or L14. Mean plasma P4 in the H14 and L14 groups were 6.6 and 6.0 ng/ml respectively, during the first week and 5.4 and 3.8 ng/ml respectively, during the second. Mean plasma P4 of 6.3 and 4.2 ng/ml were observed in H7 and L7. In experiment 2, suckled cows (n = 171) received the same PRID treatments as cows in experiment 1, plus either 375 or 750 iu pregnant mare serum gonadotrophin, and subsequent calving rates were recorded. These were significantly lower after L7 than the other treatments (12% v 38%, P less than 0.025). These results showed that fertility after oestrus was closely related to plasma P4 observed before oestrus and indicated that treatment with progesterone for as little as 1 week can produce normal fertility providing plasma P4 attain a critical threshold during treatment.     

Calving rates of Brahman and Brahman-cross cows to fixed-time insemination after treatment with pregnant mare serum gonadotrophin and intravaginal progesterone

In 2 experiments involving 151 non-lactating and 107 lactating Brahman or Brahman-cross cows, the effects of progesterone treatments (PRID) of 2 durations (7 v 14 days) and injections of pregnant mare serum gonadotrophin (PMSG) at 3 doses (O v 375 v 750 IU) were examined. All cows were inseminated with frozen/thawed semen 54 to 58 and 70 to 74 hours after PRID removal. Calving rates of non-lactating cows (38%) were unaffected by breed or treatment but were higher in previously cyclic than acyclic cows (44% v 19%, P less than 0.025) and in cows which exhibited oestrus after treatment (52% v 23%, P less than 0.001). Calving rates of lactating cows were not affected by these factors but were affected by treatment; PMSG produced no significant effect after a 7-day PRID treatment (33% overall) but increased calving rates after 14-day PRID treatments (22% v 46% v 37% for 0, 375 and 750 IU respectively, P less than 0.10). Comparisons of calving rates of lactating cows treated with 14-day PRID and PMSG and artificially inseminated, and untreated naturally mated cows, showed that treatment significantly increased the proportion of cows conceiving in the first 35 days of the mating period (50% v 23%, P less than 0.025). The results show that treatment with PRID for 14 days and PMSG can overcome post-partum anoestrus in lactating Brahman and Brahman-cross cows leading to significant reductions in the calving to conception interval.